Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03765463
Other study ID # IRB00195059
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 28, 2019
Est. completion date August 2, 2023

Study information

Verified date August 2023
Source Johns Hopkins University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Aversive sensory phenomena such as premonitory urges play a central role in the behavioral treatment model of tics. Extinction learning and extinction recall are learning processes implicated within this model, but have not been directly evaluated in youth with Tourette syndrome (TS). This study examines extinction learning and extinction recall in youth with TS using an experimental task. This study will also explore the relationship between extinction processes (i.e., extinction learning and extinction recall) and treatment outcomes with behavior therapy. Findings from this investigation will be used to update the behavioral treatment model, which serves as the basis for evidence-based behavioral interventions.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date August 2, 2023
Est. primary completion date February 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 8 Years to 17 Years
Eligibility Youth with TS will be eligible for participation if they meet the following inclusion criteria: - age 8-17 years (inclusive) - have moderate tic severity or greater as evidenced by a YGTSS Total Tic Score greater than 13 (>9 for youth with motor or vocal tics only) - have not received more than 4 previous sessions of HRT - be fluent in English. - Medication free or on a stable dose of psychiatric medication for 8 weeks prior to enrollment. Exclusion criteria for youth with TS: - An inability to complete rating scales - Attend study visits.

Study Design


Intervention

Behavioral:
Habit Reversal Training
4 sessions of habit reversal training

Locations

Country Name City State
United States Johns Hopkins University School of Medicine Baltimore Maryland

Sponsors (1)

Lead Sponsor Collaborator
Johns Hopkins University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Tic severity as assessed by the Hopkins Motor and Vocal Tic Scale (HM/VTS) Patient will nominate up to five motor and five vocal tics they deem bothersome on the HM/VTS. Each bothersome tic is then rated by a clinician on the composite two (vocal and motor) 5-point HM/VTS scale ranging from none (0) to severe (4) for the motor as well as vocal tics. The individual tic scores are summed (minimum of 0 and maximum of 40) and averaged together to create an average tic severity score. Within 1 week after completion of HRT
Secondary Tic severity as assessed by the Yale Global Tic Severity Scale-Revised (YGTSS) The YGTSS is a clinician-rated semi-structured interview that measures tic symptom severity over the previous week. It consists of 10-items that assess different dimensions of tic severity for motor and vocal tics, which are rated on a 0-5 scale. The YGTSS produces a Total Tic Score (range: 0-50), with higher ratings indicating greater tic severity. The YGTSS has demonstrated treatment sensitivity to pharmacotherapy and behavioral interventions. Within 1 week after completion of HRT
See also
  Status Clinical Trial Phase
Recruiting NCT05566236 - Board Game Project for Adolescents With Tourette Syndrome N/A
Completed NCT04114539 - Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension Phase 2
Not yet recruiting NCT06081348 - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Phase 2
Recruiting NCT05628805 - Theta Burst Stimulation to Improve Inhibitory Motor Physiology in Tourette Syndrome Early Phase 1
Recruiting NCT05558566 - Neurofeedback From the Supplementary Motor Area for Tourette Syndrome N/A
Completed NCT04578912 - Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics N/A
Not yet recruiting NCT05188274 - A Clinical Study to Evaluate the Safety and Efficacy of T92 in Pediatric Patients With Tourette Syndrome N/A
Completed NCT05184478 - Is Medicinal Cannabis an Effective Treatment for Tourette Syndrome in Adolescents? A Pilot Study Phase 1/Phase 2
Recruiting NCT05696769 - Tourette Discrimination (TD) Stigma Scale
Completed NCT04449003 - Influence of Stress and Psychiatric Symptoms on Children With Tourette Syndrome
Recruiting NCT04087616 - Internet-based CBIT for Children With Chronic Tics N/A
Completed NCT05434546 - A Study to Explore the Effect of Sepranolone in Tourette Syndrome Phase 2
Not yet recruiting NCT04179435 - Cognitive and Brain Development in Adolescents With Gilles de la Tourette Syndrome N/A
Recruiting NCT06385535 - Clinical Characteristics and Temporal Properties of Individual Tics in Persistent Tic Disorder N/A